Role of C-reactive protein in the assessment of cardiovascular risk (Q35042927)

6 August 2017

1 reference

title

Role of C-reactive protein in the assessment of cardiovascular risk (English)

1 reference

6 August 2017

Ishwarlal Jialal

1

1 reference

PubMed ID

12521635

6 August 2017

Sridevi Devaraj

series ordinal

2

1 reference

PubMed ID

12521635

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

American Journal of Cardiology

6 August 2017

1 reference

6 August 2017

91

1 reference

6 August 2017

2

1 reference

6 August 2017

200-202

1 reference

Inflammation markers and coronary heart disease

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Direct proinflammatory effect of C-reactive protein on human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Human C-reactive protein: expression, structure, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Weight loss reduces C-reactive protein levels in obese postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Effect of short-term aspirin use on C-reactive protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Effects of simvastatin (40 and 80 mg) on highly sensitive C-reactive protein in patients with combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Short-term effects of atorvastatin on C-reactive protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903110-7

10.1016/S0002-9149(02)03110-7

7 January 2021

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12521635